Evidence map›Paper›PMID 24068735›Full record

ArticleScience translational medicine2013

Human skin in the game.

Rachael A Clark

Abstract readComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Science translational medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Rachael A ClarkDepartment of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.

Funding

Vaccination to generate protective tissue resident T cellsR01AI097128 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI CLARK, RACHAEL ANN, KUPPER, THOMAS S. · 2011 to 2015
$6.1M
Immune Evasion in Human Squamous Cell Carcinomas of the SkinR01AR056720 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI CLARK, RACHAEL ANN · 2009 to 2013
$1.9M
CTCL immunobiology: lessons from alemtuzumabR01AR063962 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI CLARK, RACHAEL ANN · 2013 to 2017
$1.8M
T cell production from a skin derived thymus constructK08AI060890 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI CLARK, RACHAEL ANN · 2006 to 2009
$540k
Identification of agents that induce E-selectin on human endothelial cellsR03MH095529 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI CLARK, RACHAEL ANN · 2011 to 2012
$86k
NIAID NIH HHS K08 AI060890NIAID NIH HHS R01 AI097128NIAMS NIH HHS R01 AR056720NIAMS NIH HHS R01 AR063962NIMH NIH HHS R03 MH095529
6 · The paper itself

Abstract

Clinical and experimental observations in atopic dermatitis and psoriasis reveal new mechanisms of antiviral immunity and inflammation (Wolk et al., this issue; Kim et al., previous issue).

Indexed as

HumansInterferon LambdaInterferonsInterleukinsPsoriasisSkinTh17 CellsInterferon Lambdainterferon-lambda, humanInterferonsInterleukins

Identifiers

PMID24068735
PMCPMC4103175

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.